🌟 99% Happy customers

📦 Same-day shipping on in-stock items

Catalog Number:
38242
CAS Number:
292135-78-5
N-óxido de roflumilast
Purity:
≥ 98 % (HPLC)
Synonym(s):
3,5-Dicloro-4-[3-(ciclopropilmetoxi)-4-(difluorometoxi)benzamido]piridina-1-Óxido
Temperature Sensitive
Documents
$326.39 /5 mg
Tamaño
Request Bulk Quote
Product Information

Conservar bajo gas inerte.

Synonyms
3,5-Dicloro-4-[3-(ciclopropilmetoxi)-4-(difluorometoxi)benzamido]piridina-1-Óxido
CAS Number
292135-78-5
Purity
≥ 98 % (HPLC)
Molecular Formula
C17H14Cl2F2N2O4
Molecular Weight
419.21
MDL Number
MFCD04112984
PubChem ID
9940999
Melting Point
179 - 183 °C
Appearance
Polvo de color blanco a amarillo claro a naranja claro hasta cristal.
Conditions
Conservar a < 0 °C
General Information
Synonyms
3,5-Dicloro-4-[3-(ciclopropilmetoxi)-4-(difluorometoxi)benzamido]piridina-1-Óxido
CAS Number
292135-78-5
Purity
≥ 98 % (HPLC)
Molecular Formula
C17H14Cl2F2N2O4
Molecular Weight
419.21
MDL Number
MFCD04112984
PubChem ID
9940999
Melting Point
179 - 183 °C
Appearance
Polvo de color blanco a amarillo claro a naranja claro hasta cristal.
Conditions
Conservar a < 0 °C
Properties
Additional property information coming soon!
-
Safety and Regulations
Hazmat
No
Antibiotic
No
DEA-regulated
No
Warnings
-
Applications

Roflumilast N-oxide is widely utilized in research focused on:

  • Chronic Obstructive Pulmonary Disease (COPD) Treatment: This compound is a key player in developing medications aimed at reducing inflammation and improving lung function in COPD patients.
  • Anti-inflammatory Research: It serves as a valuable tool in studies investigating the mechanisms of inflammation, helping researchers understand how to better manage inflammatory diseases.
  • Pharmaceutical Development: Roflumilast N-oxide is used in the formulation of new drugs, offering a pathway to create more effective treatments with fewer side effects compared to existing options.
  • Respiratory Health Studies: Researchers utilize this compound to explore its effects on respiratory conditions, contributing to advancements in therapies that enhance patient quality of life.
  • Comparative Effectiveness Research: It allows scientists to compare the efficacy of different anti-inflammatory agents, providing insights that can lead to improved treatment protocols.

Citas